Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
about
Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical DilemmasA practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterusGenomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genesUterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in managementPreoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementDoes hysteroscopy worsen prognosis in women with type II endometrial carcinoma?Clinically aggressive "low-grade" uterine carcinosarcoma: A case report.Immunohistochemical characterisation of molecular subtypes in endometrial cancer.microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report.Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.In-depth molecular profiling of the biphasic components of uterine carcinosarcomas.Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.Review of Recommended Treatment of Uterine Carcinosarcoma.The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
P2860
Q28074769-949E9A6A-821E-4953-B6FE-CEED682530CCQ28077392-9AAB33B8-3403-477E-A029-6D4A3E0BF4F9Q35160677-9193CFE5-49C3-4E6C-BCC1-65D948D2326BQ35295095-DFB6BEEC-D95E-4249-81F6-02A87235A357Q35863154-6E88A0FB-77C7-40EC-BF98-B2A342F96F17Q36240990-3ABF684B-B719-4DE9-9F10-A747FD9693DDQ36320111-06D092EC-D4C2-42F6-9B2B-B8AC72D99112Q36397669-E30EA54C-5586-4396-A251-55B4CF9DB8D0Q36493409-A6F4C54A-1D16-4D85-AF88-FD6015F2E820Q37018743-69A30313-4201-4347-B935-A66EDBB5D71DQ37022647-FB1C61A4-1067-4051-AF32-E6F8B620090CQ37082531-1711A752-DC9A-4B65-BC26-52C1101F6A5BQ37272571-939092DD-6F10-499A-9980-94148E63FE7AQ38029555-77CB4FD7-1D71-42D5-BCCE-A4417C8A56B9Q38381194-41F3DF68-28BA-491B-A2B5-2F7F0F388782Q38587635-6BD6CC04-93E8-489E-9C3D-7BD12C32873FQ47757165-13E46B91-1DBC-4C15-9BB3-E86C53EBCB78
P2860
Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Molecular markers and clinical ...... he epithelial tumor component.
@en
Molecular markers and clinical ...... he epithelial tumor component.
@nl
type
label
Molecular markers and clinical ...... he epithelial tumor component.
@en
Molecular markers and clinical ...... he epithelial tumor component.
@nl
prefLabel
Molecular markers and clinical ...... he epithelial tumor component.
@en
Molecular markers and clinical ...... he epithelial tumor component.
@nl
P2093
P2860
P1433
P1476
Molecular markers and clinical ...... he epithelial tumor component.
@en
P2093
Anna Kl Reyners
H Marike Boezen
Hans W Nijman
Harry Hollema
Renske A de Jong
Tera F Wijbrandi
P2860
P2888
P304
P356
10.1038/MODPATHOL.2011.88
P577
2011-05-13T00:00:00Z
P5875
P6179
1016633049